Activation of microglia: A dangerous interlude in immune function in the brain

Neuroscientist

Volumn 2, Issue 5, 1996, Pages 293-299

  Spranger, Matthias ^a   Fontana, Adriano ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Brain injury; Brain macrophages; Cytokines; Microglia; Neurotoxicity

Indexed keywords

EID: 0000333673     PISSN: 10738584     EISSN: None     Source Type: Journal    
DOI: 10.1177/107385849600200515     Document Type: Review

References (75)

1. Ling EA, Wong WC. The origin and nature of ramified and amoeboid microglia. A historical review and current concepts. Glia 1993;7:9-18.
2. Graeber MB, Streit WJ. Microglia: immune network in the CNS. Brain Pathol 1990;1:2-5.
3. Perry VH, Gordon S. Macrophages and the nervous system. Int Rev Cytol 1991;125:203-244.
4. Perry VH, Andersson P-B, Gordon S. Macrophages and inflammation in the central nervous system. Trends Neurosci 1993;7: 268-273.
5. Celada A, Nathan C. Macrophage activation revisited. Immunol Today 1994;15:100-102.
6. Frei K, Piani D, Pfister HW, Fontana A. Immune mediated injury in bacterial meningitis. Int Rev Exp Pathol 1993;34(Pt B):183-192.
7. Giulian D, Ingemann JE. Colony stimulating factors as promotors of ameboid micoglia. J Neurosci 1988;85:317-321.
8. Imamura K, Suzumura A, Sawada M, Mabuchi C, Marunouchi T. Induction of MHC class II antigen expression on murine microglia by interleukin 3. J Neuroimmunol 1994;55:119-125.
9. Frei K, Bodmer S, Schwerdel C, Fontana A. Astrocyte derived interleukin 2 as a growth factor for microglial cells and peritoneal macrophages. J Immunol 1986;137:3521-3527.
10. Frei K, Siepl C, Groscurth P, Bodmer S, Schwerdel C, Fontana A. Antigen presentation and tumor cytotoxicity by interferon-g-treated microglial cells. Eur J Immunol 1987;17:1271-1278.
11. Banati RB, Gehrmann J, Schubert P, Kreutzberg GW. Cytotoxicity of microglia. Glia 1993;7:111-118.
12. Rosen GM, Pou S, Ramos CL, Cohen MS, Britigan BE. Free radicals and phagocytic cells. FASEB J 1995;9:200-209.
13. Gehrmann J, Bonnekoh P, Miyazawa T, Hossmann K-A, Kreutzberg GW. Immunocytochemical study of an early microglial activation in ischemia. J Cereb Blood Flow Metab 1992;12:257-269.
14. Finsen BR, Jørgensen MB, Diemer NH, Zimmer J. MHC antigen expression after ischemic and kianic acid lesions of the adult rat hippocampus. Glia 1993;7:41-49.
15. Giulian D, Vacca K. Inflammatory glia mediate delayed neuronal damage after ischemia in the central nervous system. Stroke 1993; 24 Suppl I:SI84-SI90.
16. Andersson PB, Perry VH, Gordon S. The kinetics and morphologic characteristics of the macrophage-microglia response to kianic acid-induced neuronal degeneration. Neuroscience 1991;42: 201-214.
17. Coffey PJ, Perry VH, Rawlins JNP. An investigation into the early stages of the inflammatory response following ibotenic acid induced neuronal degeneration. Neuroscience 1990;35:121-132.
18. Graeber MB, Streit WJ, Kreutzberg GW. Axotomy of the rat facial nerve leads to increased CR3 complement receptor expression by activated microglial cells. J Neurosci Res 1988;21:18-24.
19. Streit WJ, Graeber MB, Kreutzberg GW. Peripheral nerve lesion produce increased levels of major histocompatibility complex antigens in the central nervous system. J Neuroimmunol 1989;21: 117-123.
20. Dickson DW, Lee SC, Mattiace LA, Yen S-HC, Brosnan C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 1993;7:75-83.
21. McGeer PL, Kawamata T, Walker DG, Akioyma H, Tooyama I, McGeer EG. Microglia in degenerative neurological disease. Glia 1993;7:84-92.
22. Lassmann H, Schied M, Vass K, Hickey WF. Bone marrow derived elements and resident microglia in brain inflammation. Glia 1993;7:19-24.
23. Perry H, Gordon S. Macrophages and microglia in the nervous system. Trends Neurosci 1988;11:273-277.
24. Andersson PB, Perry VH, Gordon S. The acute inflammatory response to lipopolysaccharide in CNS parenchyma differs from that in other body tissues. Neuroscience 1992;48:169-186.
25. Huitinga I, Rooijen N, Groot CJA, Uitdehaag BMJ, Dijkstra CDE. Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J Exp Med 1990;172:1025-1033.
26. Gehrmann J, Gold R, Linnington C, Lannes-Vieira J, Wekerle H, Kreutzberg GW. Spinal cord microglia in experimental allergic neuritis. Lab Invest 1992;67:100-112.
27. Matsushima GK, Taniike M, Glimcher LH, et al. Absence of MHC class II molecules reduces CNS demyelination microglial/ macrophage infiltration, and twiching in murine globoid cell leukodystrophy. Cell 1994;78:645-656.
28. Malipiero U, Frei K, Fontana A. Production of hematopoietic colony stimulating factors by astrocytes. J Immunol 1990;144:3816-3821.
29. Nohava K, Malipiero U, Frei K, Fontana A. Neurons and neuroblastoma as a source of macrophage colony-stimulating factor. Eur J Immunol 1992;22:2539-2545.
30. Raivich G, Moreno-Flores MT, Moller JC, Kreutzberg GW. Inhibition of posttraumatic microglial proliferation in a genetic model of macrophage colony-stimulating factor deficiency in the mouse. Eur J Neurosci 1994;6:1615-1618.
31. Vanguri A, Farber JA. IFN and virus-inducible expression of an immediate early gene, crg-2/IP-10, and a delayed gene, I-Aα, in astrocytes and microglia. J Immunol 1994;152:1411-1418.
32. Ransohoff RM, Hamilton TA, Tani M, et al. Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J 1993;7:592-597.
33. Hayashi M, Luo Y, Laning JH, Strieter R, Dorf ME. Production and function of monocyte chemoattractant protein-1 and other β-chemokines in murine glial cells. J Neuroimmunol 1995;60:143-150.
34. Hartung H-P, Heininger K, Toyka KV. Primary astroglial cultures can generate leukotriene B4. J Neuroimmunol 1988;19:237-243.
35. Klegeris A, Walker DG, McGeer PL. Activation of macrophages by Alzheimer β amyloid peptide. Biochem Biophys Res Commun 1994;199:984-991.
36. Meda L, Cassatella MA, Szendrei GI, et al. Activation of microglial cells by β-amyloid potein and interferon-γ. Nature 1995;374: 647-649.
37. Kettenmann H, Banati R, Walz W. Electrophysiological behavior of microglia. Glia 1993;7:93-101.
38. Lee SC, Liu W, Dickson DW, Brosnan CF, Berman JW. Cytokine production by human fetal microglia and astrocytes. J Immunol 1993;150:2659-2667.
39. Frei K, Malipiero UV, Leist TP, Zinkemagel RM, Schwab ME, Fontana A. On the cellular source and function of interleukin 6 produced in the central nervous system in viral disease. Eur J Immunol 1989;19:689-694.
40. Levine B, Hardwick JM, Trapp BD, Crawford TO, Bollinger RC, Griffin DE. Antibody-mediated clearance of alphavirus infection from neurons. Science 1991;254:856-860.
41. Spranger M, Lindholm D, Bandtlow C, et al. Regulation of nerve growth factor (NGF) synthesis in the rat central nervous system: comparison between the effects of interleukin-1 and various growth factors in astrocyte cultures and in vivo. Eur J Neurosci 1989;2:69-76.
42. Bandtlow C, Meyer M, Lindholm D, Spranger M, Heumann R, Thoenen H. Regional and cellular codistribution of interleukin 1β and nerve growth factor mRNA in the adult rat brain: possible relationship to the regulation of nerve growth factor synthesis. J Cell Biol 1990;111:1701-1711.
43. Sebire G, Hery C, Peudenier S, Tardieu M. Adhesion proteins on human microglial cells and modulation of their expression by IL-1α and TNFα. Res Virol 1993;144:47-52.
44. Giulian D, Robertson C. Inhibition of mononuclear phagocytes reduces ischemic injury in the spinal cord. Ann Neurol 1990;27: 3342.
45. Renno T, Krakowski M, Piccirillo C, Lin J, Owens T. TNFα expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. J Immunol 1995;154:944-953.
46. Selmaj JW, Raine CS. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 1988;23:339-346.
47. Colton CA, Snell J, Chernyshev O, Gilbert DL. Induction of superoxide anion and nitric oxide production in cultured microglia. Ann N Y Acad Sci 1994;738:54-63.
48. Nguyen R, Brunson D, Crespi CL, Penman BW, Wishnok JS, Tannenbaum SR. DNA damage mutation in human cells exposed to nitric oxide in vitro. Proc Natl Acad Sci U S A 1992;89:3030-3034.
49. Merrill JE, Ignarro LJ, Sherman MP, Melinek J, Lane TE. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol 1993;151:2132-2141.
50. Chao CC, Hu S, Molitor TW, Shaskan EG, Peterson PK. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J Immunol 1992;149:2736-2741.
51. Tsunawki S, Sporn M, Aihao D, Nathan C. Deactivation of macrophages by transforming growth factor-β. Nature 1988;334:260-262.
52. Thery C, Chamak B, Mallat M. Cytotoxic effect of brain macrophages on developing neurons. Eur J Neurosci 1991;3:1155-1164.
53. Werns SW, Leeches BR. Free radicals and ischemic tissue injury. Trends Pharmacol Sci 1990;11:161-165.
54. Piani D, Spranger M, Frei K, Schaffner A, Fontana A. Macrophage-induced cytotoxicity of NMDA receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines. Eur J Immunol 1992;22:2429-2436.
55. Piani D, Frei K, Do KQ, Cuenod M, Fontana A. Murine brain macrophages induce NMDA receptor mediated neurotoxicity in vitro by secreting glutamate. Neurosci Lett 1991;133:159-162.
56. Giulian D, Vaca K, Noonan CA. Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science 1990;250:1593-1596.
57. Giulian D, Wendt E, Vaca K, Noonan C. The envelope glycoprotein of HIV-1 stimulates monocyte release of neurotoxins. Proc Natl Acad Sci U S A 1993;90:2769-2773.
58. Lipton AS, Sucher NJ, Kaiser PK, Dreyer EB. Synergistic effect of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron 1991;7:111-118.
59. Lipton AL. Models of neuronal injury in AIDS. Another role for the NMDA receptors. Top Neurosci 1993;15:75-79.
60. Suzumura A, Sawada M, Yamamoto H, Marunouchi T. Transforming growth factor-beta suppresses activation and proliferation of microglia in vitro. J Immunol 1993;151:2150-2158.
61. Frei K, Lins H, Schwerdel C, Fontana A. Antigen presentation in the central nervous system. The inhibitory effect of I1-10 on MHC class II expression and production of cytokine depends on the inducing signals and the type of cell analyzed. J Immunol 1994; 152:2720-2728.
62. Chao CC, Molitor TW, Hu S. Neuroprotective role of IL-4 against activated microglia. J Immunol 1993;151:1473-1481.
63. Vodovotz Y, Bogdan C, Paik J, Xie Q, Nathan C. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor β. J Exp Med 1993;178:605-613.
64. Pfister HW, Frei K, Ottnad B, Koedel U, Tomasz A, Fontana A. Transforming growth factor beta 2 inhibits cerebrovascular changes and brain edema formation in the tumor necrosis factor alpha-independent early phase of experimental pneumococcal meninigis. J Exp Med 1992;176:265-268.
65. c in the macrophage-induced glutamate dependent cytotoxicity to neurons. J Immunol 1994;152:3578-3584.
66. Cash E, Minty A, Ferrara P, Caput D, Fradelizi D, Rott O. Macrophage inactivating IL-13 suppresses experimental autoimmune encephalomyelitis in rats. J Immunol 1994;153:4258-4267.
67. Rodriguez M, Pavelko KD, McKinney CW, Leibowtiz JL. Recombinant human IL-6 supresses demyelination in a viral model of multiple sclerosis. J Immunol 1994;153:3811-3821.
68. Wesselingh SL, Levine B, Fox RJ, Choi S, Griffin DE. Intracerebral cytokine mRNA expression during fatal and nonfatal alphavirus suggests a predominant type 2 T cell response. J Immunol 1994; 152:1289-1297.
69. Li H, Newcombe J, Groone NP, Cuzner ML. Characterization and distribution of phagocytic macrophages in multiple sclerosis plaques. Neuropathol Appl Neurobiol 1993;19:214-223.
70. Hofman FM, Hinton DR, Johnson K, Merrill JE. Tumor necrosis factor a identified in multiple sclerosis brain. J Exp Med 1989; 170:607-612.
71. Boyle EA, McGeer PL. Cellular immune response in multiple sclerosis plaques. Am J Pathol 1990;137:575-584.
72. Brew BJ. The clinical spectrum and pathogenesis of HIV encephalopathy, myelopathy, and peripheral neuropathy. Curr Opin Neurol 1994;7:209-216.
73. Heyes MP, Brew BJ, Martin A, Price PL, et al. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann Neurol 1991;29:202-209.
74. Perlmutter LS, Barron E, Chui HC. Morphologic association between microglia and senile plaque amyloid in Alzheimer's disease. Neurosci Lett 1990;119:32-36.
75. Banati RB, Gehrmann J, Czech C, et al. Early and rapid de novo synthesis of Alzheimer beta A4-amyloid precursor protein (APP) in activated microglia. Glia 1993;9:199-210.